13F
中

XOMA XOMA ROYALTY CORPORATION

2026Q1 · CUSIP 98419J206 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
83
Δ holders QoQ
+10
Breadth percentile
Top 29%
Whale holders
47
Δ whales
+8
Inst. holding value
$313M
New positions
21
Closed positions
11
Price momentum (1Q)
+70.2%
Put / Call
0/3

Breadth history (34 quarters)

2018Q1: Δ+0 · h=57 2018Q2: Δ+6 · h=63 2018Q3: Δ-2 · h=61 2018Q4: Δ-10 · h=51 2019Q1: Δ+0 · h=51 2019Q2: Δ-2 · h=49 2019Q3: Δ-3 · h=46 2019Q4: Δ+9 · h=55 2020Q1: Δ-6 · h=49 2020Q2: Δ+9 · h=58 2020Q3: Δ-1 · h=57 2020Q4: Δ+5 · h=62 2021Q1: Δ-1 · h=61 2021Q2: Δ-8 · h=53 2021Q3: Δ-2 · h=51 2021Q4: Δ+3 · h=54 2022Q1: Δ+0 · h=54 2022Q2: Δ-8 · h=46 2022Q3: Δ+0 · h=46 2022Q4: Δ+3 · h=49 2023Q1: Δ+2 · h=51 2023Q2: Δ+8 · h=59 2023Q3: Δ-5 · h=54 2023Q4: Δ+6 · h=60 2024Q1: Δ-2 · h=58 2024Q2: Δ+3 · h=61 2024Q3: Δ+7 · h=68 2024Q4: Δ-2 · h=66 2025Q1: Δ+0 · h=66 2025Q2: Δ+1 · h=67 2025Q3: Δ+6 · h=73 2025Q4: Δ+0 · h=73 2026Q1: Δ+10 · h=83 2018Q1: holders=57 2018Q2: holders=63 2018Q3: holders=61 2018Q4: holders=51 2019Q1: holders=51 2019Q2: holders=49 2019Q3: holders=46 2019Q4: holders=55 2020Q1: holders=49 2020Q2: holders=58 2020Q3: holders=57 2020Q4: holders=62 2021Q1: holders=61 2021Q2: holders=53 2021Q3: holders=51 2021Q4: holders=54 2022Q1: holders=54 2022Q2: holders=46 2022Q3: holders=46 2022Q4: holders=49 2023Q1: holders=51 2023Q2: holders=59 2023Q3: holders=54 2023Q4: holders=60 2024Q1: holders=58 2024Q2: holders=61 2024Q3: holders=68 2024Q4: holders=66 2025Q1: holders=66 2025Q2: holders=67 2025Q3: holders=73 2025Q4: holders=73 2026Q1: holders=83 -10 -5 +0 +5 +10 416588 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
3
QoQ: +3

See methodology →

Fundamentals

PE (TTM)
25.6
EPS (TTM)
$1.57
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+13.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $1M 2022-09-30: $0M 2022-12-31: $1M 2023-03-31: $0M 2023-06-30: $2M 2023-09-30: $1M 2023-12-31: $2M 2024-03-31: $1M 2024-06-30: $11M 2024-09-30: $7M 2024-12-31: $9M 2025-03-31: $16M 2025-06-30: $13M 2025-09-30: $9M 2025-12-31: $14M 2026-03-31: $12M 2023-06-30: EPS -0.59 2023-09-30: EPS -0.60 2023-12-31: EPS -1.87 2024-03-31: EPS -0.86 2024-06-30: EPS 0.84 2024-09-30: EPS -1.59 2024-12-31: EPS -0.04 2025-03-31: EPS 0.06 2025-06-30: EPS 0.44 2025-09-30: EPS 0.70 2025-12-31: EPS 0.26 2026-03-31: EPS 0.17 0M 8M 16M $M -2.06 -0.57 0.92 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 27 2025-09-30: PE 28.12025-12-31: PE 16.42026-03-31: PE 26.6 15 22 30 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)